Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD)
Authors: Harry B. Burke
Journal: Annals of Internal Medicine (2015)

Letters19 May 2015Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD)Harry B. Burke, MD, PhDHarry B. Burke, MD, PhDFrom Uniformed Services University of the Health Sciences, Bethesda, Maryland.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/L15-5093 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:Collins and colleagues' article (1) is important because prediction is becoming an integral part of clinical medicine. I was gratified to note their statement that all predictions must be time-denominated (2). The authors suggest that there are only 2 types of predictions, diagnostic and prognostic, and subsume risk predictions within diagnostic predictions. I have suggested that risk is a third type of prediction (3).Risk and diagnostic predictions differ in their targets, degrees of predictive accuracy, and time intervals. In diagnostic predictions, we wish to predict whether a person has detectable disease, the disease's time interval is ...References1. Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement. Ann Intern Med. 2015;162:55-63. [PMID: 25560714] doi:10.7326/M14-0697 LinkGoogle Scholar2. Burke HB. The power of prediction [Editorial]. Cancer. 2008;113:890-2. [PMID: 18615664] doi:10.1002/cncr.23675 CrossrefMedlineGoogle Scholar3. Burke HB. Increasing the power of surrogate endpoint biomarkers: the aggregation of predictive factors. J Cell Biochem Suppl. 1994;19:278-82. [PMID: 7823601] MedlineGoogle Scholar4. Burke HB, Grizzle WE. Clinical validation of molecular biomarkers in translational medicine.. In: Srivastava S, eds. Biomarkers in Cancer Screening and Early Detection. Oxford, United Kingdom: Wiley; 2015 [Forthcoming]. Google Scholar Author, Article, and Disclosure InformationAuthors: Harry B. Burke, MD, PhDAffiliations: From Uniformed Services University of the Health Sciences, Bethesda, Maryland.Disclosures: Authors have disclosed no conflicts of interest. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterest Forms.do?msNum=L15-0100. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoTransparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): The TRIPOD Statement Gary S. Collins , Johannes B. Reitsma , Douglas G. Altman , and Karel G.M. Moons Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): The TRIPOD Statement Gary S. Collins , Johannes B. Reitsma , Douglas G. Altman , and Karel G.M. Moons Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD) Gary S. Collins , Johannes B. Reitsma , Douglas G. Altman , and Karel G.M. Moons Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD) Gary S. Collins , Johannes B. Reitsma , Douglas G. Altman , and Karel G.M. Moons Metrics Cited byGross tumour volume radiomics for prognostication of recurrence & death following radical radiotherapy for NSCLCArtificial intelligence-enabled retinal vasculometry for prediction of circulatory mortality, myocardial infarction and strokePrediction of breast cancer risk among women of the Mariana Islands: the BRISK retrospective case–control studyIntegrating genome-wide polygenic risk scores and non-genetic risk to predict colorectal cancer diagnosis using UK Biobank data: population based cohort studySupporting the ambulance service to safely convey fewer patients to hospital by developing a risk prediction tool: Risk of Adverse Outcomes after a Suspected Seizure (RADOSS)—protocol for the mixed-methods observational RADOSS projectDevelopment and validation of clinical prediction models for breast cancer incidence and mortality: a protocol for a dual cohort studyPerformance of the Hull Salford Cambridge Decision Rule (HSC DR) for early discharge of patients with findings on CT scan of the brain: a CENTER-TBI validation studyDevelopment and validation of a prehospital-stage prediction tool for traumatic brain injury: a multicentre retrospective cohort study in KoreaCharacteristics of repeat non‐attenders at Diabetes Eye Screening Wales, a national community‐based diabetes‐related retinopathy screening service, during 2003‐2018Development and validation of a score to assess complexity of general internal medicine patients at hospital discharge: a prospective cohort studyNoninvasive Determination of IDH and 1p19q Status of Lower-grade Gliomas Using MRI Radiomics: A Systematic ReviewA study protocol for a predictive algorithm to assess population-based premature mortality risk: Premature Mortality Population Risk Tool (PreMPoRT)Validation of the PredAHT-2 prediction tool for abusive head traumaPathology in the era of "Personalized Medicine": The need to learn how to integrate multivariate immunohistochemical and "omics" data with clinicopathologic information in a clinically relevant way"Development and validation of a clinical risk calculator for mortality after colectomy for fulminant Clostridium difficile colitisExternal Validation of the ELAPSS Score for Prediction of Unruptured Intracranial Aneurysm Growth RiskPredicting patient-reported and objectively measured functional outcome 6 months after ankle fracture in people aged 60 years or over in the UK: prognostic model development and internal validationFactors Associated With Outcomes of Patients With Primary Sclerosing Cholangitis and Development and Validation of a Risk Scoring SystemPredicting the presence of macrovascular causes in non-traumatic intracerebral haemorrhage: the DIAGRAM prediction scorePredicting major bleeding in patients with noncardioembolic stroke on antiplateletsIn ReplyAssociation between pre-operative statin use and major cardiovascular complications among patients undergoing non-cardiac surgery: the VISION studyPredicting Clinical Outcomes Using Molecular Biomarkers 19 May 2015Volume 162, Issue 10Page: 735KeywordsConflicts of interestDisclosure ePublished: 19 May 2015 Issue Published: 19 May 2015 Copyright & PermissionsCopyright © 2015 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...